Jiamin Zhuo
Publishes 1 feed
iSWT Community
This is the newsletter of InScienceWeTrust community that publishes weekly. We aim to share the latest news in the biotech industry, particularly in the interface of EastWest biotech collaboration space.
20 posts · contributor
Lately
Postmortem of Rumored AZ-BMS Merger; China as the Bogeyman for US Biopharma's ROI Crisis; Forte Biosciences' Little Known Proxy War
“A Fatal Reaction" That is Preventable; Jaw-Dropping TCE Data for Multiple Myeloma; China's PIONEER Program as a New R&D Accelerator
BioVerse #33 - The West-East Biotech Relay - Accelerating Affordable Innovation
The Great Rebalancing of Biotech R&D; Biggest Clinical Surprise of 2026 from AstraZeneca & Ionis; Summary of the first China BioPioneers-BioVerse Webinar
BioVerse #32 & China BioPioneers International Edition: Innovation, Globalization, and the Next Wave of ADC Development: China–West Perspectives.
A Trans-Pacific Biotech Relay Model; Pfizer ADC's Phase 3 Flop and A BioTwitter Debate Over a Newco; A Communication Guidebook for Asian Biotechs
A China CRO Selection Framework for Western Biotechs; Return to Normalcy at the FDA; Recap of the China Biotech panel from SAPA-NE Annual Conference
Conversation with Eli Lilly's Top Deal-Maker; Recap of Biotech Deal-Making Panel; Tango's Latest PRMT5 Data
BioVerse #31 - ASCO & ADA 2026 Recap - Asian Biotech On the Rise
Divergent Reception of China-Only Data from Akeso and Legend; Post-Daraxonrasib Landscape of KRAS
Pfizer-Innovent $10.5-billion deal & China biotech moments at ASCO 2026; The untold Kelun story behind its SAC-TMT
Memorial Day Weekend Listening & Reading; Boston Chapter Career Developemnet Event; ASCO 2026 Networking
Everything on this page was read from markup Jiamin Zhuo published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON